What if Cocrystallization Fails for Neutral Molecules? Screening Offered Eutectics as Alternate Pharmaceutical Materials: Leflunomide-a Case Study

Madhu Bala ¹, Manoj Kumar Gautam ¹, Renu Chadha ¹ *

Cited by CrossRef: 5

1- Acree J, Jouyban A. Comments on "What if Cocrystallization Fails for Neutral Molecules? Screening Offered Eutectics as Alternate Pharmaceutical Materials: Leflunomide-A Case Study". Pharm Sci. 2019;25(4):369 [Crossref]

2- Vasilev N, Surov A, Voronin A, Drozd K, Perlovich G. Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility. International Journal of Pharmaceutics. 2021;599:120441 [Crossref]

3- Shayanfar S, Jouyban A, Velaga S, Shayanfar A. Prediction of cocrystal formation between drug and coformer by simple structural parameters. J Rep Pharma Sci. 2022;11(2):182 [Crossref]

4- Khajir S, Shayanfar A, Monajjemzadeh F, Jouyban A. Crystal engineering of valproic acid and carbamazepine to improve hygroscopicity and dissolution profile. Drug Development and Industrial Pharmacy. 2021;47(10):1674 [Crossref]

5- Haneef J, Ali S, Chadha R. Emerging Multi-Drug Eutectics: Opportunities and Challenges. AAPS PharmSciTech. 2021;22(2) [Crossref]

Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

Follower of ICMJE